Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Nebbioso

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Pharmacology|August 7, 2018
Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase AMichela Illiano, Mariarosaria Conte, Luigi Sapio, et al.
Bioorganic & Medicinal Chemistry|February 11, 2011
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profileDante Rotili, Vincenzo Carafa, Domenico Tarantino, et al.
Bioorganic & Medicinal Chemistry|August 15, 2008
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agentsHong Su, Angela Nebbioso, Vincenzo Carafa, et al.
Chemmedchem|June 9, 2009
Pyrrole-based hydroxamates and 2-aminoanilides: histone deacetylase inhibition and cellular activitiesSergio Valente, Mariarosaria Conte, Maria Tardugno, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2009
Novel N-hydroxybenzamide-based HDAC inhibitors with branched CAP groupHong Su, Liqin Yu, Angela Nebbioso, et al.
Life Sciences|March 9, 2019
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathwayMaria Donniacuo, Konrad Urbanek, Angela Nebbioso, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Clinical Epigenetics|June 19, 2025
Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approachFederica Sarno, Jim J Jacob, Roos E Eilers, et al.
Epigenetics|October 5, 2020
Recent insights into <i>Histone Acetyltransferase-1</i>: biological function and involvement in pathogenesisAngelita Poziello, Angela Nebbioso, Hendrik G Stunnenberg, et al.
International Journal of Cancer|November 29, 2022
Interplay between m<sup>6</sup> A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectivesGuglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Pharmacology|August 7, 2018
Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase AMichela Illiano, Mariarosaria Conte, Luigi Sapio, et al.
Bioorganic & Medicinal Chemistry|February 11, 2011
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profileDante Rotili, Vincenzo Carafa, Domenico Tarantino, et al.
Bioorganic & Medicinal Chemistry|August 15, 2008
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agentsHong Su, Angela Nebbioso, Vincenzo Carafa, et al.
Chemmedchem|June 9, 2009
Pyrrole-based hydroxamates and 2-aminoanilides: histone deacetylase inhibition and cellular activitiesSergio Valente, Mariarosaria Conte, Maria Tardugno, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2009
Novel N-hydroxybenzamide-based HDAC inhibitors with branched CAP groupHong Su, Liqin Yu, Angela Nebbioso, et al.
Life Sciences|March 9, 2019
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathwayMaria Donniacuo, Konrad Urbanek, Angela Nebbioso, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Clinical Epigenetics|June 19, 2025
Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approachFederica Sarno, Jim J Jacob, Roos E Eilers, et al.
Epigenetics|October 5, 2020
Recent insights into <i>Histone Acetyltransferase-1</i>: biological function and involvement in pathogenesisAngelita Poziello, Angela Nebbioso, Hendrik G Stunnenberg, et al.
International Journal of Cancer|November 29, 2022
Interplay between m<sup>6</sup> A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectivesGuglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
Pageof 15